Background Early identification of treatment failure (TF) of nosocomial pneumonia (NP) remains a major
Introduction
Older critically ill patients clearly face an increased risk for nosocomial infection. Nosocomial pneumonia (NP) remains one of the major causes of morbidity and mortality [1, 2] . Reevaluation at 72 hours after treatment is crucial to detect the treatment failure (TF) as well as to prevent other complications [3, 4] . Unfortunately, traditional parameters failed to assess the clinical efficacy at an earlier stage. For example, fever and leukocytosis are generally considered to lack of specificity [5] ; sputum cultures are also limited due to time-consuming and difficulties in differentiating colonization from infection [6] ; chest radiography also remains a challenge in older patients since inflammatory absorption, if any, often becomes evident until the late phase of infection as well as confused by non-infection factors (e.g, pulmonary edema) [7] . The lack of an effective measures to monitor therapeutic efficacy has led to efforts aimed at biomarkers.
Procalcitonin (PCT), a 116 amino acid polypeptide and a precursor of calcitonin, was first described by Assicot as marker of bacterial infection [8] . Resent studies [9] [10] [11] have indicated that PCT is superior to other commonly used parameters in its specificity for bacterial infection and might help to guide antibiotic stewardship in lower respiratory tract infections (LRTI). However, its role for critically ill patients is still disputed [12] [13] [14] . Especially, little is known about the early time-dependent changes of PCT and its behaviors in older patients. Only a few studies at emergency department, in older patients with community associated pneumonia (CAP) or chronic obstructive pulmonary disease (COPD) exacerbation, are sparse and provide conflicting results [15] [16] [17] [18] . To date, the utility of PCT for predicting therapeutic efficacy at an earlier stage has not been assessed in older patients admitted to the intensive care unit (ICU) and requires further study.
METHODS

Study setting and population
Older patients (aged ≥65 years) admitted to our 18-bed mixed medicosurgical ICU with suspected NP were eligible from January 2009 to June 2010. Patients were excluded if they had diagnosis of immunosuppression, non-infective induced agranulocytosis, confirmed nonbacterial infection or underwent concomitant infection at other sites on admission; if they had non-microbiologically confirmed NP, nonbacterial NP, progressive infection at other sites, or incomplete determination of PCT as well as uncertain therapeutic effects due to the duration of treatment less than 5 days or incomplete clinical data at the final analysis.
This study was approved by the ethics committee of our hospital and the board exempted informed consent because of non-intervention design and retrospectively group.
Baseline assessment and data collection
Recorded data concerned age, sex, comorbid condition, patient classification (medical or surgery), and prior hospitalization before ICU admission. The following data were obtained on days 0, 3, and 7, and at the end of treatment (EOT) (designated D 0 , D 3 , D 7 , and D e , respectively): white cell count (WCC) ; body temperature; the results of sputum culture; PCT ; chest radiography and other laboratory tests required to calculate the modified clinical pulmonary infection score (mCPIS) [19] , Acute Physiology and Chronic Health Evaluation (APACHE) II score [20] , and Sequential Organ Failure Assessment (SOFA) score [21] ; the presence or absence of infection at other sites, appropriate antimicrobial treatment ( the drug had an in vitro activity against the isolated strain), duration of mechanical ventilation , ICU lengths of stay and 28-day ICU crude mortality.
Study design
This was a prospective observational study and treatment decisions were left up to clinicians. On admission, all patients were immediately applied empirical antimicrobial therapy. After that, the modifications were according to the culture results and the treatment response. The duration of treatment was continued for at least 8 days in patients with uncomplicated pneumonia, and for at least 2 to 3 weeks (decisions according to therapeutic response and severity of illness) in those with concomitant bacteremia or MDR infection (defined as resistance to ≥3 classes of antimicrobial agents, including cephalosporins, aztreonam, carbapenems, aminoglycosides, fluoroquinolones and so on) [4] . Mechanical ventilation and airway management were performed in accordance with a standard protocol [22] .
Microbiological processing and procalcitonin assay
Respiratory samples were obtained by tracheal aspiration, bronchoalveolar lavage or sputum specimen. Only good-quality specimens (< 10 epithelial cells and > 25 WBCs per low-power field) were semiquantitative culture and more than 3+ of microbial culture growth was considered as positive [23] . PCT concentrations were measured using the commercially available immunoluminometric assay system (Brahms PCT LIA; Berlin, Germany). Functional assay sensitivity was defined as the lowest value with an interassay coefficient of RESPIRATORY CARE Paper in Press. Published on December 10, 2013 as DOI: 10.4187/respcare.02364
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variance (CV) < 20% of 0.1 µg/L. Change rate in PCT ( ∆PCT%) was calculated using the following formula:
∆ PCT DX % = (PCT D0 -PCT DX ) ⁄ PCT D0 * 100. Its values >0 indicated decreasing PCT concentrations. Conversely, indicated unchanged or increasing PCT. All assays were performed according to the manufacturers' instructions and standard microbiology guidelines [23, 24] .
Definitions and outcome measures
NP was suspected when a patient who was in hospital or residing in a long-term care facility ( > 48 hours) or present < 7 days after a patient was discharged from the hospital with initial hospitalization of ≥ 3 days developed a new and persistent radiographic infiltrate plus 2 of the following: (1) body temperature > 38°C or < 36°C; (2) WCC > 11,000/mm 3 or < 4,000/mm 3 ; and (3) a macroscopically purulent tracheal aspirate [28] .
Diagnosis of severe NP was defined using ATS guidelines [26] and met any one of the following conditions: (1) shock defined as systolic BP of < 90 mmHg or diastolic BP of < 60 mmHg; (2) Clinical efficacy was assessed within the five days of EOT or the third weeks of antimicrobial treatment by investigators and categorized as clinical improvement (complete or partial resolution of signs and symptoms of pneumonia) and no improvement (deterioration or no improvement of signs and symptoms) [25] . Microbiologic responses were classified as eradication (including presumed microbiologic eradication) or persistence (including presumed microbiologic persistence) based on culture results and clinical responses.
Statistical analyses
SPSS 13.0 for Windows (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. Normally distributed parameters were expressed as mean ± SD and compared using the Student's t-test. Non-normally distributed parameters were expressed as median (ranges) and analyzed using the rank sum test. Unordered RESPIRATORY CARE Paper in Press. Published on December 10, 2013 as DOI: 10.4187/respcare.02364
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categorical variables were expressed as percentages, and the difference was analyzed using the chi-square test.
Logistic regression analysis was used to analyze the influential factors of clinical efficacy. The predictive ability was estimated by using receiver-operating characteristic curve (ROC). All tests were 2-tailed, and p values < 0.05 were considered statistical significance.
Results
Patients characteristics
During the study period, of 291 ICU patients (aged ≥65 years), 107 had suspected NP and 47 were excluded ( the reasons for exclusion are listed in Figure 1） . A total of 60 patients were included. The mean age was 70. 
Serum PCT concentrations and influential factors
PCT concentrations were measured in 365 samples taken from eligible patients and were analysed in 240 samples from enrolled patients. PCT were elevated (>0.5µg/L) in all patients on day 0 and the median levels 
The influential factors of clinical efficacy
In contrast with the improvement group, no improvement patients were significantly older ( 75. were independent predictors of TF.
Discussion
PCT and its kinetics as the way to assess the clinical efficacy at an earlier stage were addressed in older patients with NP. Our findings suggested that PCT kinetics within the first 72 hours of sepsis management may be a useful tool for predicting TF and might provide an opportunity to modify antibiotics and improve outcome.
First of all, elevated PCT were observed in all patients with severe bacterial NP and also observed to be RESPIRATORY CARE Paper in Press. Published on December 10, 2013 as DOI: 10.4187/respcare.02364
associated with severity of illness, whereas, the type of pneumonia, MDR infection or renal function were not.
These findings suggested that PCT kinetics may not be influenced by aging and serve as an indicator of the severity of bacterial infection. PCT release mechanism may be one explanation for this: it originated from various tissues and cells ( e.g., fat, liver, stomach, lung ) and its level was strongly associated with the degree and extensity of sepsis, but specific bacterial strains or source of infection as well as impaired renal function
were not [ 9, [27] [28] [29] [30] . Indeed, a relatively high PCT was used in comparison with study using a PCT of 0.38µg/L or more for diagnosis of bacterial infection in older patients [ 17 ] . Differences in the case mix ( higher propotion of surgical patients were included) and critical severity (higher propotion of septic shock and higher SOFA scores) may contribute to higher PCT [31] [32] [33] Second, PCT kinetics within the first 72 hours was also found to be significantly different, since a decrease ≥26.2% was expected in the patients with improvement, and was regarded as an independent predictor of clinical efficacy. As a result, patient management might be reassessed if PCT fell slowly (such as less than 26.2%
between D 0 and D 3 ). In such cases, modification to initial empirical thearpy may be considered while the microbiological findings, if any, are still pending. On the contrary, absolute PCT failed to predict clinical efficacy due to the fact that it was affected by various factors, including concurrent infection at other sites, severity of infection, trauma or surgery [ 34 ] . Similarly, mCPIS is also not suitable for patients with trauma, surgery or acute respiratory distress syndrome [ 35, 36 ] , but better predictive ability was observed when combined with PCT kinetics.
Interestingly, PCT kinetics not serving as a marker of clinical efficacy, but indicting microbiologic eradication, could help to distinguish the improvement patients from those no improvement. This result was consistent with the experimental data: the PCT time course is thought to be closely dependent on bacterial load and the host response to microbial challenge [37] . PCT kinetics may offer a solution for the dilemma about positive sputum cultures ( interpretation of colonization or infection) and guide appropriate duration of antibiotics. Epub ahead of print papers have been peer-reviewed and accepted for publication but are posted before being copy edited and proofread, and as a result, may differ substantially when published in final version in the online and print editions of RESPIRATORY CARE.
de-escalation algorithm (antibiotics were stopped if the PCT fell by more than 80% of its peak value) [12, 14] .
Further studies are required to estimate the exact threshold of PCT for predicting therapeutic efficacy at an earlier stage.
Limitations
We are aware of the limitations of our study. First, the single centric study and small sample size may restrict further subgroup analysis (such as VAP, MDR infection). Second, the lack of gold standard for diagnosis NP and enrolled only patients with microbiologically confirmed NP may lead to selection bias. Third, we couldn't determine whether the predictive value of ∆PCT D3 % is equally applicable in very older individuals due to few patients > 90 years of age. Finally, whether the ideal strategy involves the use of the PCT kinetics to affect sepsis management in this crowd remains to be established.
Conclusions
Among older critically ill patients with NP, PCT and kinetics were not influenced by aging and might help to For ∆PCT D3 % > 26.2% and mCPIS < 6 points, the AUC was 0.890; sensitivity, 81.3%; and specificity, 86.5%.
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